Dasatinib 70mg Tablets Exporters

* To be consumed as directed by physician.

Dasatinib 70mg Tablets

Dasatinib (70mg)
  • Dasatinib 70mg tablet is a chemotherapy drug. It is an ATP-competitive protein tyrosine kinase inhibitor. It mainly targets BCR/ABI (the Philadelphia chromosome), SRC, c-Kit, ephrin receptors, and several other tyrosine kinases.
  • Dasatinib Tablets have half-life plasma that is active only for 3 to 4 hours, but the strong binding to BCR-ABL1 helps it to stay active for a long time, and this is the uniqueness of Dasatinib when compared to other CML treatments.
  • The dosage of the medicine depends upon the severity of the complications of the disease, and it may vary gradually depending on the response of the body to the medicine.
  • Dasatinib 20mg is used to treat cases of Chronic Myelogenous Leukemia (CML) Acute Lymphoblastic Leukemia (ALL), and Philadelphia Chromosome-positive (Ph+).
  • It blocks the action of the abnormal protein that strengthens the cancer cells to multiply.
  • It stops or slows down the growth of cancer cells in the body.
  • It treats the adults in the chronic phase of Philadelphia Chromosome-positive (Ph+) who have no benefits from or couldn’t tolerate other treatments and children who have chronic Ph+ CML.
  • Dasatinib affects the rhythm of the heartbeat, therefore if you observe irregular heartbeat, dizziness, or fainting), call for medical help immediately.
  • Let your doctor know if you are allergic to any of the ingredients of the medicine and have a medical history of heart, kidneys, liver, recent infections, or any bleeding problems and medications that you are already on.
  • Contact us for inquiries, quotations, or information. We are the leading manufacturers, bulk suppliers, and global exporters of the product.
(4.9 Rating)

Product Enquiry

Send Message